Skip to Content

Gate 322 Lofibra 67 mg (Lofibra 67 mg)

Generic Name: fenofibrate

Pill with imprint Gate 322 Lofibra 67 mg is Pink, Capsule-shape and has been identified as Lofibra 67 mg. It is supplied by Gate Pharmaceuticals.

Lofibra is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia type iib, elevated ldl vldl; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia; hyperlipoproteinemia type v, elevated chylomicrons vldl and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Lofibra 67 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Gate 322 Lofibra 67 mg

Lofibra 67 mg Gate 322 Lofibra 67 mg
Lofibra 67 mg Gate 322 Lofibra 67 mg
Lofibra 67 mg Gate 322 Lofibra 67 mg
Lofibra 67 mg Gate 322 Lofibra 67 mg

Lofibra

Generic Name
fenofibrate
Imprint
Gate 322 Lofibra 67 mg
Strength
67 mg
Color
Pink
Size
14.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Fibric acid derivatives
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Gate Pharmaceuticals
National Drug Code (NDC)
57844-0322
Inactive Ingredients
croscarmellose sodium, lactose monohydrate, magnesium stearate, povidone k25, corn starch, sodium lauryl sulfate, magnesium silicate, D&C Red No. 28, FD&C Blue No. 1, FD&C Red No. 40, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.